Krueger named CEO of hospital

by ZACH VEILLEUX

In a reorganization of senior leadership at The Rockefeller University Hospital effective July 1, James Krueger has been named chief executive officer, the organization’s highest administrative post. He takes over from Barbara O’Sullivan, who has served as CEO since 2005. Dr. O’Sullivan will retain her position as hospitalist and will also become medical director, a post formerly held by Dr. Krueger.

The switch will allow Dr. O’Sullivan to refocus on clinical operations, patient care and patient safety, and to work more closely with nursing and support staff. It will also make better use of Dr. Krueger’s extensive administrative experience and nearly 20 years of tenure at the hospital. He was medical director of the General Clinical Research Center from 1996 to 2006 and has been codirector of the Center for Clinical and Translational Science since 2006.

Dr. Krueger, who is also head of the Laboratory for Investigative Dermatology, will assume responsibility for all aspects of the hospital’s finances and functions. “The hospital and the associated Center for Clinical and Translational Science provide important resources to basic and clinical researchers for human interface science,” says Dr. Krueger. “I am honored to be able to continue to work with Drs. O’Sullivan and Coller to make Rockefeller’s hospital the best possible for this kind of cutting edge work.”

Under Dr. O’Sullivan, the hospital undertook a department-by-
department reorganization over three years, focused on enhancing workflow and improving coordination of efforts, as well as on providing a clearer line of communication between the hospital and the rest of the university. “I am proud of the strong team we have built at the hospital,” says Dr. O’Sullivan. “This change reflects my efforts, and the efforts of others, to build greater administrative support for hospital operations. The reorganization will make the most of the talents of our staff.”